The Discounted Cash Flow (DCF) valuation of Theradiag SA (ALTER.PA) is (2.45) EUR. With the latest stock price at 1.26 EUR, the upside of Theradiag SA based on DCF is -294.7%.
Based on the latest price of 1.26 EUR and our DCF valuation, Theradiag SA (ALTER.PA) is a sell. selling ALTER.PA stocks now will result in a potential gain of 294.7%.
Note: valuation result may not be accurate due to the low predictability of business.
| Range | Selected | |
| WACC / Discount Rate | 4.9% - 6.2% | 5.5% |
| Long-term Growth Rate | 3.0% - 4.6% | 3.8% |
| Fair Price | (18.30) - (1.21) | (2.45) |
| Upside | -1552.3% - -195.9% | -294.7% |